key: cord-1011042-0vkhn1d5
authors: Turan, Şenol; Poyraz, Burç Çağrı; Poyraz, Cana Aksoy; Demirel, Ömer Faruk; Aydın, Ezgi Tanrıöver; Bostan, Büşra Uçar; Demirel, Öznur; Ali, Ritvan Kara
title: Characteristics and Outcomes of COVID-19 Inpatients Who Underwent Psychiatric Consultations
date: 2021-01-28
journal: Asian J Psychiatr
DOI: 10.1016/j.ajp.2021.102563
sha: ecfe25412a3ba283ad28f8318ddbbf4348962189
doc_id: 1011042
cord_uid: 0vkhn1d5

Patients hospitalized with COVID-19 are at risk of developing many neuropsychiatric disorders, due to the effects of the disease on the brain and the psychosocial pressures of having the disease. The aim of the present study was to evaluate the characteristics and outcomes of patients who were hospitalized with a diagnosis of COVID-19, who underwent psychiatric consultations. The medical records of 892 patients hospitalized due to COVID-19 and the 89 among them who requested psychiatric consultations were analyzed retrospectively. After the psychiatric consultations, patients were most frequently diagnosed with delirium (38.2%), adjustment disorder (27.0%), depressive disorder (19.1%) and anxiety disorder (11.2%). Patients with delirium had longer hospital stays (p < .001), were transferred more frequently to intensive care units (p < .001), and had higher mortality rates during their hospital stays (p < .001), than all other patients. The need for oxygen (p < .001) and mechanical ventilation (p < .001) was also significantly higher in delirium patients, as well as in patients who received other psychiatric diagnoses. Neuropsychiatric disorders develop in patients receiving inpatient treatments in COVID-19 wards, and these disorders negatively affect the prognosis of COVID-19. Our findings suggest that the presence of neuropsychiatric disorders in in-patients with COVID-19 might be associated with the negative outcomes of the disease.

Coronavirus disease 2019 , which is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has already affected more than 85 million people and caused over 1.8 million deaths worldwide since the first case was confirmed, in Wuhan, China, in late December of 2019. The clinical presentations of COVID-19 can vary according to the severity of the disease in the individual. However; the most common reported symptoms are fever, cough, dyspnea, and upper respiratory tract symptoms, including myalgias, diarrhea, and smell or taste disorders (Goyal et al., 2020; Guan et al., 2020; Huang et al., 2020; Richardson et al., 2020; Stokes et al., 2020) .

While SARS-CoV-2 is known to primarily cause disease in the lungs, it is reported that its effects are not limited to the lungs and expands to other organs such as the brain, heart, kidneys, skin, and gastrointestinal organs (Baj et al., 2020; Roberts et al., 2020; Yuki et al., 2020) .

Coronaviruses are known to have neuropathogenic potential (Desforges et al., 2014; Kotfis et al., 2020) . It has been demonstrated that severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS), which are the other members of the coronaviridae family, have potential neurotrophic effects (Lau et al., 2004; Li et al., 2016; Xu et al., 2005) . In a recent meta-analysis study by Rogers et al. (2020) , it was demonstrated that coronaviruses have serious psychiatric and neuropsychiatric outcomes, both in the acute stage and in the long term. This systematic review revealed that the most common symptoms among patients admitted to hospitals for SARS or MERS included insomnia (41.9%), anxiety (35.7%), impaired memory (34.1%), depressed mood (32.6%), and confusion (27.9%) during the acute stage.

Similarly, growing evidence suggests that SARS-CoV-2 may also cause neurological and psychiatric symptoms by affecting the brain (Troyer et al., 2020; Varatharaj et al., 2020; Vindegaarda and Benrosa, 2020) . In a study by Nalleballe et al. (2020) , which evaluated 40,469 COVID-19 infected patients, the neuropsychiatric manifestations rate was found to be 22.5% (n=9086). While the most common neurologic manifestations in this study were headaches (3.7%), sleep disorders (3.4%), and encephalopathy (2.3%), and the most common psychiatric symptoms were anxiety and other related disorders (4.6%), as well as mood disorders (3.8%). These emerging neuropsychiatric manifestations may occur due to the direct effects of the virus on the brain, the indirect immune responses or the medical treatments administered (Rogers et al., 2020) . On the other hand, psychiatric disorders developing in the acute period in patients hospitalized for COVID-19 may arise due to concerns about the consequences of the disease (Banerjee 2020; Xiang et al., 2020) , such as social isolation and quarantine (Brooks et al., 2020; Lewnard and Lo, 2020) , unemployment, financial difficulties (Chaves et al., 2018) , and stigma (Banerjee 2020) .

In Turkey, the first confirmed case of COVID-19 was reported on March 11 th , 2020. In the time period since, the data leading up to January 6 th 2020 shows that there have been 2,283,921 people diagnosed with the disease, including 22,070 people that have died as a result of the disease in Turkey (Republic of Turkey Ministry of Health   Corona Table, 2020) . Since the confirmation of the first case, many public and private hospitals were declared "pandemic hospitals" by the government, to combat COVID-19.

In this context, new inpatient wards where only COVID-19 patients were treated were established.

The aim of this study was to quantify the characteristics and outcomes of patients who were hospitalised in the pandemic wards of ………… University at the height of the outbreak with a diagnosis of COVID-19 and who received psychiatric consultations. A further objective of this study was to identify factors associated with the neuropsychiatric symptoms these patients experienced.

All patients over the age of 18 who were hospitalized during the COVID-19 pandemic in the wards of ……….. University, ………. Medical Faculty Hospital and received consultations from the department of psychiatry between the 10 th of March, 2020, and 26 th of June, 2020, were included in the study. The patients were divided into two groups; "confirmed cases" and "probable cases", according to the case definitions of the World Health Organization (WHO, Public health surveillance for COVID-19: interim guidance, 2020). Regardless of clinical signs and symptoms, individuals with laboratory confirmations of COVID-19 were categorized as "confirmed cases." The "probable cases" included: (1) patients who met clinical criteria (acute onset of fever and cough; or acute onset of any three or more of the following signs or symptoms: fever, cough, general weakness/fatigue, headache, myalgia, sore throat, coryza, dyspnoea, anorexia/nausea/vomiting, diarrhoea, altered mental status) and were in contact with an individual with a probable or confirmed case, or epidemiologically linked to a cluster of individuals, at least one of whom had a confirmed case; (2) suspected cases due to (3) having received in-patient treatment in a COVID-19 ward. Patients whose file information was not available and whose first hospitalization took place in the intensive care units (ICU) were not included in the study.

Nasal and pharyngeal swab specimens were collected on admission to the hospital. The diagnosis of COVID-19 was confirmed by reverse transcriptase-polymerase chain reaction (RT-PCR) assays for SARS-Cov-2 RNA.

The consultations were retrospectively reviewed using information obtained from medical file records and electronic medical records. Two consultant psychiatrists and an infectious disease specialist prepared a structured data collection form in order to determine the sociodemographic and clinical features of the patients. This form included questions on the patients' age and gender, the clinical features of their COVID-19 diagnosis, their PCR test results, chest imaging findings, hospitalization period dates, ICU transfer information, intubation status and final status. The form also included information on their reason for requesting a psychiatric consultation, their psychiatric history, the psychiatric diagnosis given to them, the treatment recommendations made and whether there was need for reconsultation. The structured data collection form was filled out by three psychiatry residents from the department of consultation-liaison psychiatry.

Patients were evaluated by a psychiatrist at their consultations in the COVID-19 wards where they were hospitalized. The consultants entered the rooms of patients with J o u r n a l P r e -p r o o f COVID-19 cases with personal protective equipment provided for them in order to reduce their risk of exposure. Personal protective equipment included a gown, gloves, respirators (N95), medical masks, goggles, and disposable face shields. The anamnesis, examination findings, pre-diagnosis and treatment recommendations of the patients were recorded in the consultation forms in their medical files and in the electronic medical record system. Psychiatric diagnoses were made according to the International Statistical Classification of Diseases and Related Health Problems, 10th revision (ICD-10).

The data were analyzed using the Statistical Package for the Social Sciences, version 22.0 (SPSS Inc, Chicago, IL). Characteristics of patients were described using mean and standard deviations, median or counts and proportions, as appropriate.

Differences between the groups (patients who received no consultations, patients with delirium, and patients with other psychiatric diagnoses) were tested using the chisquare test for categorical variables and a one-way analysis of variance (ANOVA) for continuous variables.

We investigated the patient records of 927 individuals above 18 years of age, who were hospitalized with a diagnosis of COVID-19. The records of all patients were accessed. Thirty-five patients hospitalized at first in the ICU with the above diagnoses were excluded. Out of a total of 892 patients (Male=412, 46.2%), 89 patients (10.0%;

Male=36, 40.5%) requested psychiatric consultations. The average age was 55.6 years (Table 1) . Patients were consulted mostly on the first day of their hospitalization J o u r n a l P r e -p r o o f (19.3%), with a median consultation date of their third day (range=1-89). RT-PCR positivity was detected in 46 patients (51.7%) in the first or consecutive test. The most common reasons for requesting psychiatric consultation were psychomotor agitation/restlessness (25.8%), impairment of sleep (23.6%), evaluation of prior psychiatric treatment (16.7%), anxiety/fear (14.6%), and suicidal ideation (9.0%) ( Table 1) . After the psychiatric evaluations were performed during their consultations, the patients were diagnosed with either delirium (38.2%), adjustment disorder (27.0%), depressive disorder (19.1%), or anxiety disorder (11.2%) ( Table 2) . Table 3 . Nineteen of 34 patients with delirium (56%) and four of the 55 patients with a psychiatric diagnosis (7.4%) had previous neuropsychiatric conditions.

Characteristics n (%) 

In the present study, psychiatric consultations requested by patients hospitalized with a probable or confirmed diagnosis of COVID-19 in pandemic wards in a tertiary hospital were retrospectively examined.

In this study, we found that a psychiatric consultations were requested by 10.0 % of patients hospitalized in COVID-19 wards. In studies conducted in Europe (Huyse et al., 2001; Rothenhausler et al., 2001) , and Turkey (Özmen and Aydemir, 1993; Aslan ve ark., 2003; Canan et al. 2008; Ekmekçi Ertek and Öztürk, 2019) , the rate of requesting psychiatric consultations for inpatients in general hospital wards varies between 1.2% and 2.8%. It can be said that this rate is high. However, there are studies reporting that the prevalence of psychiatric disorders in inpatients varies between 26.1% and 38.7% (Silverstone, 1996; Arolt et al., 1997; Martucci et al., 1999; Hansen et al., 2001) .

According to the results of our study, it has been observed that the most common reasons for requesting psychiatric consultations were psychomotor agitation/restlessness, impairment of sleep, evaluation of prior psychiatric treatments, anxiety/fear and suicidal ideation, respectively. In general, it can be said that the reasons for requesting consultations in the present study (although the frequency and order varied) did not differ from the results of previous studies of patients in general hospital wards (Göktaş et al., 2006; Wilson et al, 2012; Eser et al., 2018) . However, a small number of studies conducted with patients with COVID-19 found that these complaints were more common in patients after psychiatric evaluations (Helms et al., 2020; Iqbal et al., 2020) . In a recent study investigating psychiatric morbidity in patients with COVID-19 (Iqbal et al., 2020) who were referred to the consultation-liaison psychiatry service, it was reported that the most common symptoms of patients were insomnia (70%), anxiety (64%), agitation (50%) and depressive mood (42%). Similarly, J o u r n a l P r e -p r o o f the study conducted by Xie et al. (2020) looked at patients who were experiencing the first episode of their mental disorders and were hospitalized with or without a diagnosis of COVID-19. The study went onto compare the two groups to show that the most common symptoms in those diagnosed with COVID-19 were insomnia (72%), aggressive behaviors (64.0%), delusion (40.0%), and severe anxiety (36.0%).

In the present study, the most common diagnosis made after the psychiatric consultations was delirium. Delirium is a syndrome of acute brain failure that is common in medical wards (Inouye et al., 2014; Thom et al., 2019) , and is a well-known complication of respiratory diseases such as pneumonia (O'Hanlon and Inouye, 2020) .

Knowledge about the neuroinvasive character of SARS-CoV-2 (Iadecola et al., 2020; Kotfis et al., 2020; Li et al., 2020; Orsini et al., 2020) and the neuropsychiatric consequences of the disease it causes (Mao et al., 2020; Orsini et al., 2020; Rogers et al., 2020) increases with every day. In this context, it can be said that it is no surprise that COVID-19 causes delirium. To our knowledge, in the only study evaluating psychiatric consultations in COVID-19 wards, Iqbal et al. (2020) reported that delirium was 26% in a sample of 98% males with a mean age of 43.9. In our study, the rate of delirium diagnosis was higher in patients who requested a consultation (38.2%). This may be due to the higher mean age of our sample (55.6). Studies that examined the geriatric population hospitalized with COVID-19, reported that the delirium rate was between 26.7% (Annweiler et al., 2020) , 27.5% (Marengoni et al., 2020) and 42% (Mcloughlin et al., 2020) . In another recent study in which 707 patients over the age of 50 were evaluated, the delirium rate was found to be 33% (Garcez et al., 2020) . The results of our study show that more than half of the delirium patients (56%) had a neuropsychiatric diagnosis and almost all of them (97%) had a chronic medical disease. It is known that these two conditions predispose the development of delirium. In hindsight, it can be said J o u r n a l P r e -p r o o f that delirium develops at high rates during COVID-19, and that clinicians should focus more on this situation (Garcez et al., 2020; O'Hanlon and Inouye, 2020) .

We found that psychiatric consultations were requested by patients hospitalized in COVID-19 wards, mostly within the first three days of their admission. Bianchetti et al. (2020) found that the most frequent symptom of onset was delirium (67%) among dementia patients diagnosed with COVID-19. Similarly, Poloni et al. (2020) emphasized that delirium may be representative of an early-phase clinical feature of COVID-19, especially in elderly patients. In this context, it becomes clear that clinicians should be alert of the fact that delirium may develop, especially in the first days of hospitalization.

Delirium is known to be a negative prognostic predictor (Inouye et al., 2014) .

Early studies indicated that delirium in elderly patients with COVID-19 was strongly associated with in-hospital mortality (Garcez et al., 2020; Marengoni et al., 2020) . We found that delirium patients stayed longer in hospitals, were transferred to the ICU more frequently than other patients, and needed more oxygen treatment and mechanical ventilation. Their mortality rates were also higher during hospitalization. Given these results, frequent delirium screenings are of great importance for the assessment and management of COVID-19 (O'Hanlon and Inouye, 2020) .

In our study, the most common diagnosis made after the psychiatric consultations, following delirium, were adjustment disorder, depressive disorder and anxiety disorder, respectively. The COVID-19 pandemic can trigger a range of stressors related to an individuals' health status. Some of these may include being in quarantine, unemployment, financial difficulties and stigma, that can lead to adaptation difficulties in many suffering from the disease. Unsurprisingly, this complex array of stressors can J o u r n a l P r e -p r o o f lead to psychiatric problems such as adjustment disorder, depression, and anxiety (Kazlauskas and Quero, 2020; Lotzin et al., 2020; Mazza et al., 2020; Xie et al., 2020) . and, the majority of the patients were those living in urban areas. It is important to note that all of these circumstances limit the generalizability of these findings.

It can be said that various psychiatric disorders develop in patients who are hospitalized for COVID-19, as a result of both the effects of the disease on the central nervous system and the psychosocial problems caused by the disease. After the psychiatric consultations, we found that the most common diagnosis was delirium, and that the development of it negatively affected the prognosis of COVID-19. On the other hand, we observed that other psychiatric disorders such as adjustment disorder, depression and anxiety were common in patients hospitalized in COVID-19 wards and were associated with a more severe course of COVID-19. Our findings indicate that the presence of neuropsychiatric disorders in patients hospitalized with COVID-19 may be associated with the negative outcomes of the disease. In this context, our study is important as it draws attention to the fact that in-patients with COVID-19 should be evaluated frequently for neuropsychiatric disorders resulting from the disease. It is clear that consultation-liaison psychiatry services will make important contributions to combating the global COVID-19 pandemic.

The authors have no conflicts of interest to declare.

None.

This study was approved by the Istanbul University -Cerrahpaşa, Cerrahpaşa Medical Faculty's Ethical Committee.

National French survey of COVID-19 symptoms in people aged 70 and over

The Lübeck General Hospital Study. I: Prevalence of psychiatric disorders in medical and surgical inpatients

Central nervous system manifestations of COVID-19: A systematic review

Bir üniversite hastanesinde bir yıl süresince gerçekleştirilen psikiyatri konsültasyon hizmetlerinin değerlendirilmesi

COVID-19: Specific and Non-Specific Clinical Manifestations and Symptoms: The Current State of Knowledge

The COVID-19 outbreak: Crucial role the psychiatrists can play

Clinical Presentation of COVID19 in Dementia Patients

The psychological impact of quarantine and how to reduce it: rapid review of the evidence

Bir üniversite hastanesinde yatan hastalar için istenen psikiyatri konsültasyonlarının değerlendirilmesi

Neurological complications of coronavirus and COVID-19

The impact of economic recessions on depression and individual and social well-being: the case of Spain

Human coronaviruses: viral and cellular factors involved in neuroinvasiveness and neuropathogenesis

Bir eğitim-araştırma hastanesinde istenen psikiyatri konsültasyonlarının değerlendirilmesi ve psikiyatrik hastalıkların doğru tanınma oranları

Bir üniversite hastanesinde yatan hastalar için ve acil servisten istenilen ruh sağlığı ve hastalıkları konsültasyonlarının incelenmesi: Türkiye'den çalışmalarla bir karşılaştırma

Delirium and Adverse Outcomes in Hospitalized Patients with COVID-19

Clinical Characteristics of Covid-19

Bir Eğitim hastanesinde istenen psikiyatri konsültasyonlarının değerlendirilmesi

China Medical Treatment Expert Group for Covid-19., 2020. Clinical Characteristics of Coronavirus Disease 2019 in China

Mental disorders among internal medical inpatients: prevalence, detection, and treatment status

Neurologic Features in Severe SARS-CoV-2 Infection

Clinical features of patients infected with 2019 novel coronavirus in Wuhan

Consultation-Liaison psychiatric service delivery: results from a European study

Effects of COVID-19 on the Nervous System

Delirium in elderly people

Psychiatric presentation of patients with acute SARS-CoV-2 infection: a retrospective review of 50 consecutive patients seen by a consultation-liaison psychiatry team

Adjustment and coronavirus: How to prepare for COVID-19 pandemic-related adjustment disorder worldwide?

COVID-19: ICU delirium management during SARS-CoV-2 pandemic

Possible central nervous system infection by SARS coronavirus

Scientific and ethical basis for social-distancing interventions against COVID-19

Middle East Respiratory Syndrome Coronavirus Causes Multiple Organ Damage and Lethal Disease in Mice Transgenic for Human Dipeptidyl Peptidase 4

The neuroinvasive potential of SARS-CoV2 may play a role in the respiratory failure of COVID-19 patients

Stressors, coping and symptoms of adjustment disorder in the course of the COVID-19 pandemic -study protocol of the European Society for Traumatic Stress Studies (ESTSS) pan-European study

Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease

The impact of delirium on outcomes for older adults hospitalised with COVID-19

Evaluating psychiatric morbidity in a general hospital: a two-phase epidemiological survey

Anxiety and depression in COVID-19 survivors: Role of inflammatory and clinical predictors

Spectrum of neuropsychiatric manifestations in COVID-19

Delirium: a missing piece in the COVID-19

Challenges and management of neurological and psychiatric manifestations in SARS-CoV-2 (COVID-19) patients

Bir genel hastanede istenen psikiyatri konsültasyonları, Nöropsikiyatri Arşivi

Prevalence and prognostic value of Delirium as the initial presentation of COVID-19 in the elderly with dementia: An Italian retrospective study

the Northwell COVID-19 Research Consortium

Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the

COVID-19: a complex multi-system disorder

Psychiatric and neuropsychiatric presentations associated with severe coronavirus infections: a systematic review and meta-analysis with comparison to the COVID-19 pandemic

Changes in patterns of psychiatric referral in a German general hospital: results of a comparison of two 1-year surveys 8 years apart

Prevalence of psychiatric disorders in medical inpatients

Coronavirus Disease 2019 Case Surveillance -United States

COVID-19 Bilgilendirme Sayfası

Are we facing a crashing wave of neuropsychiatric sequelae of COVID-19? Neuropsychiatric symptoms and potential immunologic mechanisms

Neurological manifestations and implications of COVID-19 pandemic

CoroNerve Study Group, 2020. Neurological and neuropsychiatric complications of COVID-19 in 153 patients: a UK-wide surveillance study

COVID-19 pandemic and mental health consequences: Systematic review of the current evidence

Comorbidities and multi-organ injuries in the treatment of COVID-19

The psychopharmacology of agitation: consensus statement of the american association for emergency psychiatry project

World Health Organization. International Statistical Classification of Diseases and Related Health Problems, 10th revision (ICD-10)

Public health surveillance for COVID-19: interim guidance

Timely mental health care for the 2019 novel coronavirus outbreak is urgently needed

COVID-19 patients managed in psychiatric inpatient settings due to first-episode mental disorders in Wuhan, China: clinical characteristics, treatments, outcomes, and our experiences

Detection of severe acute respiratory syndrome coronavirus in the brain: potential role of the chemokine mig in pathogenesis

COVID-19 pathophysiology: A review

None.